Keywords: sanofi-aventis, growth, slowing, question, being, raised, about
Sanofi-Aventis: is growth slowing?
Article | 01 August 2005
The question being raised about the Franco-European drugmaker Sanofi-Aventis is whether its growth is beginning to slow down. Second-quarter 2005 sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
